Third IV fund has not been sold, says VP, but it does have a major new investor
Mathan Ganesan confirms that the firm will continue to monetise the 3,000 patents in the fund and that the deal indicates overall market conditions are improving
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.